Kala Pharmaceuticals competitorsClear all

Kala Pharmaceuticals's top competitors include Biogen, MyoKardia and Alimera Sciences.
Kala Pharmaceuticals
Kala Pharmaceuticals
Kala is a clinical stage pharmaceutical company focused on innovative nanoparticle-based treatments for ocular diseases affecting both front and back of the eye.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Alimera Sciences
Alimera Sciences
Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
Founding Date
Founding Date
2009
Founding Date
1978
Founding Date
2012
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Watertown, US HQ
Waltham, US
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
South San Francisco, US HQ
Brisbane, US
Locations
Alpharetta, US HQ
Berlin, DE
Dublin 2, IE
Lisboa, PT
Hampshire, GB
Employees
Employees
3748% increase
Employees
7,4005% decrease
Employees
23542% increase
Employees
1222% decrease
Valuation ($)
Valuation ($)
434.5 m
Valuation ($)
39.3 b
Valuation ($)
11.9 b
Valuation ($)
21.7 m
Twitter followers
Twitter followers
N/A
Twitter followers
34.4 k
Twitter followers
1.1 k
Twitter followers
2.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
50
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
11.1
Average likes per tweet (last 30 days)
8.4
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
345658
Alexa Website Rank
254464
Alexa Website Rank
239431
Alexa Website Rank
344430
Employee Rating
Employee Rating
5
Employee Rating
3.9
Employee Rating
4.2
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$53.9m (FY, 2019)
Net income
Net income
($33.2m) (FY, 2016)
Net income
$5.9b (FY, 2019)
Net income
($276.2m) (FY, 2019)
Net income
($10.4m) (FY, 2019)

Operating

Patents (US)
Patents (US)
6 (FY, 2016)
Patents (US)
21 (FY, 2019)
Patents (US)
2 (FY, 2018)
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
11 (Q2, 2020)
Phase I Trials Products
1 (FY, 2018)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (Q2, 2020)
Phase II Trials Products
2 (FY, 2018)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
6 (Q2, 2020)
Phase III Trials Products
1 (FY, 2018)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 114.2m
Total funding raised
N/A
Total funding raised
$ 98m
Total funding raised
$ 232.6m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
MyoKardia
HQ
South San Francisco, US
Employees
235↑ 42% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Alimera Sciences
HQ
Alpharetta, US
Employees
122↓ 2% decrease

Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.

View company